Antidiabetic effect of kaempferol a flavonoid compound, on streptozotocin-induced diabetic rats with special reference to glycoprotein components

Progress in Nutrition

Volumn 17, Issue 1, 2015, Pages 50-57

  Chandramohan, Govindasamy ^a   Al Numair, Khalid S ^a   Alsaif, Mohammed A ^a   Veeramani, Chinnadurai ^a  

^a KING SAUD UNIVERSITY   (Saudi Arabia)

Author keywords

Diabetes; Glycoproteins; Kaempferol; Plasma glucose; Streptozotocin

Indexed keywords

FUCOSE; GLIBENCLAMIDE; GLUCOSE; GLYCOPROTEIN; HEXOSAMINE; HEXOSE; KAEMPFEROL; SIALIC ACID;

ADULT; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIDIABETIC ACTIVITY; CONTROLLED STUDY; GLUCOSE BLOOD LEVEL; HEART; KIDNEY; LIVER; MALE; MORNING DOSAGE; NONHUMAN; OUTCOME ASSESSMENT; PROTEIN BLOOD LEVEL; RAT; REVIEW; STREPTOZOTOCIN-INDUCED DIABETES MELLITUS; TISSUE LEVEL; WISTAR RAT;

RATTUS;

EID: 84934279256     PISSN: 11298723     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (46)

1. Komosínska-Vassev K, Olczyk K, Olczyk P and Winsz- Szczotka K. Effects of metabolic control and vascular complications on indices of oxidative stress in type 2 diabetic patients. Diab Res Clin Pract 2005; 68: 207-216.
2. Babu PVA, Sabitha KE and Shyamaladevi CS. Therapeutic effect of green tea extract on oxidative stress in aorta and heart of streptozotocin-diabetic rats. Chemico-Biol Int 2006; 162: 114-120.
3. Baily CJ and Flatt PR. Antidiabetic drugs, new developments. Indian Biotech 1986; 6: 139-142.
4. Mittal N, Keaur J and Mahmood A. Changes in tubular membrane glycosylation in diabetic insulin and thyroxin treated rat kidneys. Ind J Exp Biol 1996; 34: 782-785.
5. Knecht KT, Bradford BU, Mason RP and Thurman RG. In vivo formation of free radicals metabolite of ethanol. Mol Pharmacol 1990; 38: 26-30.
6. Sharma C, Dalferes FR, Radhakrishnamurthy B, De-Paolo CJ and Berenson GS. Hepatic glycoprotein synthesis in streptozotocin diabetic rats. Biochem Int 1987; 36: 15-19.
7. Peppa M, Stavroulakis P and Raptis SA. Advanced glycoxidation products and impaired diabetic wound healing. Wound Repair Regen 2009; 17; 461-472.
8. Patti ME, Virkamaki A, Landaker EJ, Kahan CR and ki- Jarvinen H. Activation of the hexosamine pathway by glucosamine in vivo induces insulin resistance of early post receptor insulin signaling events in skeletal muscle. Diabetes 1999; 48: 1562-1571.
9. Subramoniam A, Pushpangadan P, Rajasekaran S, Evans DA, Latha PG and Valsaraj R. Effects of Artemisia pallens wall On blood glucose levels in normal and alloxan-induced diabetic rats. J Ethnopharmacol 1996; 50: 13-17.
10. Mukherjee PK, Saha K, Pal M and Saha BP. Effect of Nelumbo nucifera rhizome extract on blood sugar level in rats. J Ethnopharmacol 1997; 58: 207-213.
11. Akpan HB, Adefule AK, Fakoya FA and Caxton-Martins EA. Evaluation of LDH and G6-PDH activities in auditory relay centers of streptozotocin-induced diabetic wistar rats. J Anal Sci 2007; 1: 21-25.
12. Ross JA and Kasum CM. Dietary flavonoids: Bioavailability, metabolic effects, and safety. Annu Rev Nutr 2002; 22: 19-34.
13. Yoshida T, Konishi M, Horinaka M, Yasuda T, Goda AE and Taniguchi H. Kaempferol sensitizes colon cancer cells to TRAIL-induced apoptosis. Biochem. Biophys Res Commun 2008; 375: 129-33.
14. Kampkötter A, Gombitang Nkwonkam C, Zurawski RF, Timpel C, Chovolou Y and Wätjen W. Effects of the flavonoids kaempferol and fisetin on thermotolerance, oxidative stress and FoxO transcription factor DAF-16 in the model organism Caenorhabditis elegans. Arch Toxicol 2007: 81; 849-858.
15. Kim JM, Lee EK, Kim DH, Yu BP and Chung HY. Kaempferol modulates pro-inflammatory NF-kappaB activation by suppressing advanced glycation endproducts-induced NADPH oxidase. Age (Dordr.) 2010; 32: 197-208.
16. Nguyen TT, Tran E, Ong CK, Lee SK, Do PT and Huynh TT. Kaempferol-induced growth inhibition and apoptosis in A549 lung cancer cells is mediated by activation of MEK-MAPK. J Cell Physiol 2003; 197: 110-121.
17. Geleijnse JM, Launer LJ, Van der Kuip DA, Hofman A and Witteman JC. Inverse association of tea and flavonoid intakes with incident myocardial infarction: The Rotterdam Study. Am J Clin Nutr 2002; 75: 880-886.
18. Knekt P, Kumpulainen J, Järvinen R, Rissanen H, Heliövaara M, Reunanen A. Flavonoid intake and risk of chronic diseases. Am J Clin Nutr 2002; 76: 560-568.
19. Lin J, Zhang SM, Wu K, Willett WC, Fuchs CS and Giovannucci E. Flavonoid intake and colorectal cancer risk in men and women. Am J Epidemiol 2006; 164: 644-651.
20. Fang XK, Gao J and Zhu DN. Kaempferol and quercetin isolated from Euonymus alatus improve glucose uptake of 3T3-L1 cells without adipogenesis activity. Life Sci 2008; 82: 615-622.
21. Lee YJ, Suh KS, Choi MC, Chon S, Oh S and Woo JT. Kaempferol protects HIT-T15 pancreatic beta cells from 2-deoxy-D-ribose-induced oxidative damage. Phytother Res 2010; 24: 419-423.
22. Al-Numair KS, Chandramohan G, Veeramani C and Alsaif MA. Influence of kaempferol on lipid metabolic changes in streptozotocin induced diabetic rats. Prog Nutr 2013; 15: 255-264.
23. Niebes P. Determination of enzymes and degradation products of glycosaminoglycan metabolism in the serum of healthy and various subjects. Clin Chim Acta 1972; 42: 399-408.
24. Elson LA and Morgon WT. A Colorimetric method for the determination of glucosamine and galactosamine. Biochem J 1933; 27: 1824-1828.
25. Dische Z and Shettles LB. Special colorimetric reaction of methyl pentoses and a spectrophotometric micromethod for their determination. J Biol Chem 1948; 175: 595-604.
26. Welmer HE, Moshine JR and Sailcin D. Distribution of glycoproteins in normal human plasma. Am Rev Tuberc 1952; 68: 594.
27. Nathan DM. Long-term complications of diabetes mellitus. New Eng J Med 1993; 328(23): 1676-1685.
28. Latner A. Clinical Biochemistry, Saunders, Philadelphia 1958; 48.
29. Robinson KA, Weinstein MP, Lindenmayer GE and Byse MG. Effects of diabetes and hyperglycemia on the hexosamine synthesis pathway in rat muscle and liver. Diabetes 1955; 44: 1438-1446.
30. Shanmugasundram ERB, Gopinath KL, Shanmugasundram KR and Rajendran VM. Possible regeneration of islets of Langerhans in streptozotocin diabetic rats given Gymnema sylvestre leaf extract. J Ethnopharmacol 1990; 30: 265-279.
31. Bhathena SJ, Velásquez MT and Am J. Beneficial role of dietary phytoestrogens in obesity and diabetes. Clin Nutr 2002: 76; 1191-1201.
32. Li JM, Che CT, Lau CBS, Leung PS and Cheng CHK. Inhibition of intestinal and renal Na+-glucose cotransporter by naringenin. Int J Biochem Cell Biol 2006; 38: 985-95.
33. Youngren JF, Maddux BA, Sasson S, Sbraccia P, Tapscott EB and Swanson MS. Skeletal musle content of membrane glycoproteins PC-1 in obesity. Relationship of muscle glucose transport. Diabetes 1996; 45: 585-587.
34. Al-Numair KS, Chandramohan G and Alsaif MA. Influence of camel milk on glycoprotein components in streptozotocin- diabetic rats. J Camel Pract Res 2011; 18: 15-20.
35. Berenson GS and Radhakrishnamurthy Dalferes ER. Connective tissue macromolecular changes in rats with experimentally induced diabetes and hyperinsulinism. Diabetes 1972; 21: 733-743.
36. Spiro RG and Spiro MJ. Effect of diabetes on the biosynthesis of the renal glomerular basement membrane. Studies on the glycosyl transferase. Diabetes 1971: 20; 641-48.
37. Guillot R, Kassab JP, Ogneva U, Andre J, Durussel JJ and Hadjiisky P. Relation between pancreatic islet cellular infiltration and plasma fibrinogen or [alpha] 1-acid glycoprotein levels in spontaneously and streptozotocin-diabetic rats: An increase in these protein levels is not necessary for inducing microcirculatory erythrocyte velocity alteration. Pancreas 1994; 9: 336-343.
38. Saravanan G, Ponmurugan P, Senthil Kumar GP and Rajarajan T. Antidiabetic effect of S-allylcysteine: Effect on plasma and tissue glycoproteins in experimental diabetes. Phytomedicine 2010; 17(14): 1086-1089.
39. Kimmelsteil P and Wilson C. Inter capillary lesion in the glomeruli of the kidney. Am J Pathol 1936; 12: 83-105.
40. Rasch R, Torffucit O, Bachmann S, Jensen PK and Jacobsen NO. Glycoprotein in streptozotocin diabetic rats: A study of kidney in situ hybridization, immunohistochemistry and urinary excretion. Diabetologia 1955; 32: 525-535.
41. Camerini Davalos RA, Velasco CA and Reddi AS. Metabolism of glomerular basement membrane in diabetes. In: Belfiore, F., Molinatti, G. M., Reaven, G. M. (Eds.), Frontiers in Diabetes. Karger, Basel, Switzerland 1990; 61-77.
42. Goldberg S, Harvey SJ, Cunningham J, Tryggvason K and Miner JH. Glomerular filtration is normal in the absence of both agrin and perlecan-heparan sulfate from the glomerular basement membrane. Nephrol Dial Transplant 2009; 24(7): 2044-2051.
43. Ghassan MS, Ahmed AHA, Abbas AM and Ali AAT. The effect of cherry sticks extract on the levels of glycoproteins in alloxan induced experimental diabetic mice. Ann Clin Lab Sci Winter 2012; 42; 34-41.
44. Judd JT and Wexler BC. Myocardial connective tissue metabolism in response to injury. II. Investigation of the mucopolysaccharides involved in isoproterenol-induced necrosis and repair in rat hearts. Circ Res 1970; 26: 101- 109.
45. Thornalley PJ. Glycation and/or polyol pathway inducing complications. Encycloped Endocrine Dis 2004; 2: 257-278.
46. Marshall S, Bacote V and Traxinger RR. Discovery of metabolic pathway mediating glucose induced desensitization of glucose transport system: Role of hexosamine biosynthesis in the induction of insulin resistance. J Biol Chem 1991; 266: 4706-4712.